Brain perfusion patterns in familial frontotemporal lobar degeneration

Neurology

Volumn 77, Issue 4, 2011, Pages 384-392

  Seelaar, H ^a   Papma, J M ^a   Garraux, G ^b,c   De Koning, I ^a   Reijs, A E ^a   Valkema, R ^a   Rozemuller, A J M ^d   Salmon, E ^b,c   Van Swieten, J C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Cyclotron Research Center   (Belgium)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRANULIN; TAR DNA BINDING PROTEIN; TAU PROTEIN;

ADULT; AGED; APATHY; APRAXIA; ARTICLE; BRAIN PERFUSION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FRONTAL GYRUS; FRONTOTEMPORAL DEMENTIA; GENDER; GENE MUTATION; HUMAN; LANGUAGE DISABILITY; MALE; MEMORY DISORDER; MOTOR NEURON DISEASE; OBSESSIVE COMPULSIVE DISORDER; PARIETAL LOBE; PARKINSONISM; PERFUSION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

EID: 80051525764     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182270456     Document Type: Article

References (40)

1. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Groupon Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803-1809. (Pubitemid 33044246)
2. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705.
3. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442: 916-919. (Pubitemid 44285946)
4. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006;442: 920-924. (Pubitemid 44285947)
5. Seelaar H, Kamphorst W, Rosso SM, et al. Distinct genetic forms of frontotemporal dementia. Neurology 2008; 71:1220-1226.
6. Rohrer JD, Guerreiro R, Vandrovcova J, et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009;73:1451-1456.
7. van Swieten J, Spillantini MG. Hereditary frontotemporal dementia caused by tau gene mutations. Brain Pathol 2007;17:63-73.
8. Pickering-Brown SM, Rollinson S, Du Plessis D, et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain 2008;131:721-731. (Pubitemid 351294717)
9. van Swieten JC, Heutink P. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol 2008;7:965-974.
10. Whitwell JL, Jack CR Jr, Boeve BF, et al. Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology 2009;72:813-820.
11. Rohrer JD, Ridgway GR, Modat M, et al. Distinct profiles of brain atrophy in frontotemporal lobar degeneration caused by progranulin and tau mutations. Neuroimage Epub 2010.
12. Snowden JS, Pickering-Brown SM, Mackenzie IR, et al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain 2006;129:3091-3102. (Pubitemid 44684528)
13. Masellis M, Momeni P, Meschino W, et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain 2006;129:3115-3123. (Pubitemid 44684530)
14. Le Ber I, Camuzat A, Hannequin D, et al. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain 2008;131: 732-746. (Pubitemid 351294727)
15. Cruchaga C, Fernandez-Seara MA, Seijo-Martinez M, et al. Cortical atrophy and language network reorganization associated with a novel progranulin mutation. Cereb Cortex 2009;19:1751-1760.
16. Rosso SM, Donker Kaat L, Baks T, et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 2003;126:2016-2022. (Pubitemid 37059441)
17. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414. (Pubitemid 23346995)
18. Brand N, Jolles J. Learning and retrieval rate of words presented auditorily and visually. J Gen Psychol 1985;112: 201-210.
19. Seelaar H, Schelhaas HJ, Azmani A, et al. TDP-43 pathology in familial frontotemporal dementia and motor neuron disease without progranulin mutations. Brain 2007; 130:1375-1385. (Pubitemid 47355944)
20. Seelaar H, Klijnsma KY, de Koning I, et al. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration. J Neurol 2010;257: 747-753.
21. Sampathu DM, Neumann M, Kwong LK, et al. Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 2006;169:1343-1352. (Pubitemid 351194368)
22. Van Laere KJ, Versijpt J, Koole M, et al. Experimental performance assessment of SPM for SPECT neuroactivation studies using a subresolution sandwich phantom design. Neuroimage 2002;16:200-216. (Pubitemid 34852484)
23. Kim EJ, Cho SS, Jeong Y, et al. Glucose metabolism in early onset versus late onset Alzheimer's disease: an SPM analysis of 120 patients. Brain 2005;128:1790-1801. (Pubitemid 41373650)
24. Friston KJ, Holmes AP, Worsley KJ, Poline JB, Frith CD, Frackowiak RSJ. Statistical parametrical maps in functional imaging: a general linear approach. Hum Brain Mapp 1995;2:189-210. (Pubitemid 124008664)
25. Yakushev I, Landvogt C, Buchholz HG, et al. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18. Psychiatry Res 2008;164:143-153.
26. Whitwell JL, Przybelski SA, Weigand SD, et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain 2009; 132:2932-2946.
27. Boxer AL, Mackenzie IR, Boeve BF, et al. Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry Epub 2010.
28. Whitwell JL, Warren JD, Josephs KA, et al. Voxel-based morphometry in tau-positive and tau-negative frontotemporal lobar degenerations. Neurodegener Dis 2004;1:225-230. (Pubitemid 39551801)
29. Kim EJ, Rabinovici GD, Seeley WW, et al. Patterns of MRI atrophy in tau positive and ubiquitin positive frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2007;78:1375-1378. (Pubitemid 350221422)
30. Grossman M, Libon DJ, Forman MS, et al. Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia. Arch Neurol 2007;64:1601-1609. (Pubitemid 350106761)
31. Pereira JM, Williams GB, Acosta-Cabronero J, et al. Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration. Neurology 2009;72:1653-1660.
32. Whitwell JL, Jack CR Jr, Senjem ML, et al. MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration. Neurodegener Dis 2009;6:106-117.
33. Kobayashi S, Tateno M, Utsumi K, et al. Quantitative analysis of brain perfusion SPECT in Alzheimer's disease using a fully automated regional cerebral blood flow quantification software, 3DSRT. J Neurol Sci 2008;264:27-33. (Pubitemid 350184065)
34. Bastin C, Feyers D, Souchay C, et al. Frontal and posterior cingulate metabolic impairment in the behavioural variant of frontotemporal dementia with impaired autonoetic consciousness. Hum Brain Mapp Epub 2011 Apr 21.
35. Matsuda H. Role of neuroimaging in Alzheimer's disease, with emphasis on brain perfusion SPECT. J Nucl Med 2007;48:1289-1300. (Pubitemid 47242794)
36. Salmon E, Lekeu F, Garraux G, et al. Metabolic correlates of clinical heterogeneity in questionable Alzheimer's disease. Neurobiol Aging 2008;29:1823-1829.
37. Guedj E, Le Ber I, Lacomblez L, et al. Brain SPECT perfusion of frontotemporal dementia associated with motor neuron disease. Neurology 2007;69:488-490. (Pubitemid 47450285)
38. Habert MO, Lacomblez L, Maksud P, El Fakhri G, Pradat JF, Meininger V. Brain perfusion imaging in amyotrophic lateral sclerosis: extent of cortical changes according to the severity and topography of motor impairment. Amyotroph Lateral Scler 2007;8:9-15. (Pubitemid 46331209)
39. Whitwell JL, Jack CR Jr, Boeve BF, et al. Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations. Neurology 2009;73:1058-1065.
40. Rabinovici GD, Furst AJ, O'Neil JP, et al. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration. Neurology 2007;68:1205-1212. (Pubitemid 46608468)